Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

the clorox co. - CLX

CLX

Close Chg Chg %
99.69 0.21 0.21%

Closed Market

99.90

+0.21 (0.21%)

Volume: 2.39M

Last Updated:

Nov 6, 2026, 3:59 PM EDT

Trade Now

Company Overview: the clorox co. - CLX

CLX Key Data

Open

$96.69

 Day Range

96.22 - 100.54

52 Week Range

79.12 - 128.87

 Market Cap

$12.01B

Shares Outstanding

121.15M

 Public Float

120.39M

Beta

0.58

 Rev. Per Employee

N/A

P/E Ratio

17.85

 EPS

$5.57

Yield

499.50%

 Dividend

$1.25

EX-DIVIDEND DATE

Oct 28, 2026

 SHORT INTEREST

N/A

AVERAGE VOLUME

2.65M

  

CLX Performance

1 Week
 
 13.59%
 
1 Month
 
 19.28%
 
3 Months
 
 -4.94%
 
1 Year
 
 -6.89%
 
5 Years
 
 -38.77%
 

CLX Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 21
Full Ratings ➔

About the clorox co. - CLX

The Clorox Co. engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States. The Household segments consists of bags and wraps, grilling products and cat litter marketed and sold in the United States. The Lifestyle segment refers to food, natural personal care products and water-filtration products marketed and sold in the United States. The International segment covers products sold outside the United States, excluding natural personal care products. The company was founded by Edward Hughes, Charles Husband, William Hussey, Rufus Myers, and Archibald Taft on May 3, 1913 and is headquartered in Oakland, CA.

CLX At a Glance

The Clorox Co.
1221 Broadway
Oakland, California 94612-1888
Phone 1-510-271-7000 Revenue 6.72B
Industry Household/Personal Care Net Income 587.00M
Sector Consumer Non-Durables Employees 9,200
Fiscal Year-end 06 / 2027
View SEC Filings

CLX Valuation

P/E Current 17.852
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 19.857
Price to Sales Ratio 1.735
Price to Book Ratio 128.236
Price to Cash Flow Ratio 19.05
Enterprise Value to EBITDA 15.34
Enterprise Value to Sales 2.57
Total Debt to Enterprise Value 0.324

CLX Efficiency

Revenue/Employee 730,434.783
Income Per Employee 63,804.348
Receivables Turnover 8.496
Total Asset Turnover 1.006

CLX Liquidity

Current Ratio 0.658
Quick Ratio 0.378
Cash Ratio 0.052

CLX Profitability

Gross Margin 41.815
Operating Margin 13.08
Pretax Margin 11.771
Net Margin 8.735
Return on Assets 8.791
Return on Equity 285.645
Return on Total Capital 10.32
Return on Invested Capital 15.387

CLX Capital Structure

Total Debt to Total Equity 6,220.00
Total Debt to Total Capital 98.418
Total Debt to Total Assets 71.824
Long-Term Debt to Equity 4,898.889
Long-Term Debt to Total Capital 77.514
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for The Clorox Co. - CLX

Collapse All in section
All values USD millions. 2023 2024 2025 2026 5-year trend
Sales/Revenue
7.39B 7.09B 7.10B 6.72B
Sales Growth
+3.97% -4.01% +0.16% -5.41%
Cost of Goods Sold (COGS) incl D&A
4.52B 4.07B 3.91B 3.91B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
236.00M 235.00M 219.00M 247.00M
Depreciation
206.00M 206.00M 198.00M 219.00M
Amortization of Intangibles
30.00M 29.00M 21.00M 28.00M
COGS Growth
- -2.12% -9.96% -3.88%
Gross Income
2.87B 3.02B 3.19B 2.81B
Gross Income Growth
+15.25% +5.36% +5.59% -12.02%
Gross Profit Margin
+38.86% +42.65% +44.96% +41.82%
2023 2024 2025 2026 5-year trend
SG&A Expense
2.04B 2.11B 2.02B 1.93B
Research & Development
139.00M 126.00M 121.00M 116.00M
Other SG&A
1.91B 1.98B 1.89B 1.81B
SGA Growth
+13.87% +3.18% -4.46% -4.17%
Other Operating Expense
- - - -
-
Unusual Expense
- 505.00M 187.00M (70.00M)
EBIT after Unusual Expense
322.00M 729.00M 1.25B 879.00M
Non Operating Income/Expense
19.00M (228.00M) (70.00M) 55.00M
Non-Operating Interest Income
16.00M 23.00M 9.00M 8.00M
Equity in Earnings of Affiliates
4.00M 5.00M 4.00M 3.00M
Interest Expense
103.00M 103.00M 101.00M 143.00M
Interest Expense Growth
- +6.19% -1.94% +41.58%
Gross Interest Expense
103.00M 103.00M 101.00M 143.00M
Interest Capitalized
- - - -
-
Pretax Income
238.00M 398.00M 1.08B 791.00M
Pretax Income Growth
-60.79% +67.23% +170.85% -26.62%
Pretax Margin
+3.22% +5.61% +15.17% +11.77%
Income Tax
77.00M 106.00M 254.00M 190.00M
Income Tax - Current - Domestic
186.00M 150.00M 204.00M 51.00M
Income Tax - Current - Foreign
40.00M 56.00M 68.00M 58.00M
Income Tax - Deferred - Domestic
(148.00M) (104.00M) (19.00M) 82.00M
Income Tax - Deferred - Foreign
(1.00M) 4.00M 1.00M (1.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
4.00M 5.00M 4.00M 3.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
161.00M 292.00M 824.00M 601.00M
Minority Interest Expense
12.00M 12.00M 14.00M 14.00M
Net Income
149.00M 280.00M 810.00M 587.00M
Net Income Growth
-67.75% +87.92% +189.29% -27.53%
Net Margin Growth
+2.02% +3.95% +11.40% +8.74%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
149.00M 280.00M 810.00M 587.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
149.00M 280.00M 810.00M 587.00M
EPS (Basic)
1.2056 2.2549 6.5574 4.8204
EPS (Basic) Growth
-67.87% +87.04% +190.81% -26.49%
Basic Shares Outstanding
123.59M 124.17M 123.53M 121.78M
EPS (Diluted)
1.1999 2.2435 6.5172 4.8063
EPS (Diluted) Growth
-67.82% +86.97% +190.49% -26.25%
Diluted Shares Outstanding
124.18M 124.80M 124.29M 122.13M
EBITDA
1.06B 1.15B 1.40B 1.13B
EBITDA Growth
+15.54% +8.28% +21.46% -19.46%
EBITDA Margin
+14.39% +16.23% +19.68% +16.76%

Snapshot

Average Recommendation HOLD Average Target Price 94.625
Number of Ratings 21 Current Quarters Estimate 0.984
FY Report Date 12 / 2026 Current Year's Estimate 5.725
Last Quarter’s Earnings 1.55 Median PE on CY Estimate N/A
Year Ago Earnings 5.53 Next Fiscal Year Estimate 6.154
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 15 15 17 17
Mean Estimate 0.98 1.49 5.72 6.15
High Estimates 1.05 1.60 5.80 6.44
Low Estimate 0.87 1.39 5.65 5.74
Coefficient of Variance 5.43 3.82 0.82 3.25

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 2
OVERWEIGHT 0 0 0
HOLD 15 16 15
UNDERWEIGHT 1 1 1
SELL 3 3 4
MEAN Hold Hold Hold

Insider Actions for The Clorox Co. - CLX

Date Name Shares Transaction Value
Oct 8, 2026 Linda Rendle Chief Executive Officer; Director 269,807 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $80.41 per share 21,695,180.87
Oct 8, 2026 Luc Bellet EVP - Chief Financial Officer 74,860 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $80.41 per share 6,019,492.60
Oct 8, 2026 Luc Bellet EVP - Chief Financial Officer 75,891 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $80.41 per share 6,102,395.31
Oct 8, 2026 Luc Bellet EVP - Chief Financial Officer 76,471 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $80.41 per share 6,149,033.11
Oct 8, 2026 Chris T. Hyder EVP-Chief Operating Officer 92,986 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $80.41 per share 7,477,004.26
Oct 8, 2026 Chris T. Hyder EVP-Chief Operating Officer 94,518 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $80.41 per share 7,600,192.38
Oct 8, 2026 Chris T. Hyder EVP-Chief Operating Officer 94,618 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $80.41 per share 7,608,233.38
Oct 8, 2026 Laura Peck VP - CAO & Corp Controller 10,017 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $80.41 per share 805,466.97
Oct 8, 2026 Laura Peck VP - CAO & Corp Controller 10,356 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $80.41 per share 832,725.96
Oct 8, 2026 Laura Peck VP - CAO & Corp Controller 10,386 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $80.41 per share 835,138.26
Oct 8, 2026 Angela C. Hilt EVP - Chief Legal Officer 74,414 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $80.41 per share 5,983,629.74
Oct 8, 2026 Linda Rendle Chief Executive Officer; Director 281,796 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $80.41 per share 22,659,216.36
Oct 8, 2026 Linda Rendle Chief Executive Officer; Director 282,488 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $80.41 per share 22,714,860.08
Oct 8, 2026 Nina Barton EVP-Chief Growth & Strategy Of 36,179 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $80.41 per share 2,909,153.39
Oct 8, 2026 Kirsten M. Marriner EVP - Chief Admin Officer 79,498 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $80.41 per share 6,392,434.18
Oct 8, 2026 Kirsten M. Marriner EVP - Chief Admin Officer 81,640 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $80.41 per share 6,564,672.40
Oct 8, 2026 Kirsten M. Marriner EVP - Chief Admin Officer 83,591 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $80.41 per share 6,721,552.31
Oct 8, 2026 Angela C. Hilt EVP - Chief Legal Officer 69,767 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $80.41 per share 5,609,964.47
Oct 8, 2026 Angela C. Hilt EVP - Chief Legal Officer 72,118 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $80.41 per share 5,799,008.38

The Clorox Co. in the News